Mylan sues Celgene for blocking Revlimid, Thalomid generics
(Reuters) - Mylan Inc on Thursday sued Celgene Corp to stop the latter's effort to keep generic versions of two drugs that generate $4.5 billion of an...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/3svQzMPbs3w/story01.htm
No comments:
Post a Comment